Results on benefits and harms of mammographic screening differ substantially between studies. The reasons why will be discussed at an expert conference on breast cancer screening in Oslo, Norway, January 31. The conference is organized by the Cancer Registry of Norway.
About 200 participants have signed up for a conference in Oslo January 31, 2013 to learn about the methodological challenges associated with evaluation of results from mammographic screening.
The conference with experts from Norway and abroad is organized by the Cancer Registry of Norway, which is responsible for the Norwegian Breast Cancer Screening Programme.
The speakers will focus on why the effect estimates of mammographic screening, such as breast cancer mortality, as well as overdiagnosis, and false positive screening results, vary between different studies.
- The benefits and harms of mammographic screening have been discussed for decades. It is now time to move forward, discuss and understand the different study designs and assumptions used in the different studies, and their implications for the outcome, says Solveig Hofvind, senior researcher at the Cancer Registry and member of the organizing committee.